Crocè, Saveria
 Distribuzione geografica
Continente #
NA - Nord America 9.012
EU - Europa 4.984
AS - Asia 1.656
AF - Africa 75
SA - Sud America 35
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 15.790
Nazione #
US - Stati Uniti d'America 8.880
IT - Italia 1.188
PL - Polonia 1.037
SE - Svezia 811
UA - Ucraina 595
CN - Cina 571
SG - Singapore 396
HK - Hong Kong 363
DE - Germania 354
FI - Finlandia 220
BG - Bulgaria 191
TR - Turchia 162
IE - Irlanda 153
CA - Canada 126
GB - Regno Unito 125
CH - Svizzera 62
FR - Francia 59
SN - Senegal 54
RU - Federazione Russa 48
BE - Belgio 43
VN - Vietnam 42
NL - Olanda 30
IN - India 25
KR - Corea 25
CZ - Repubblica Ceca 18
BR - Brasile 16
JP - Giappone 13
EG - Egitto 11
ES - Italia 11
ID - Indonesia 11
IR - Iran 11
PH - Filippine 11
AU - Australia 10
EU - Europa 10
RO - Romania 10
IL - Israele 7
AR - Argentina 6
DK - Danimarca 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
AT - Austria 4
HR - Croazia 4
KE - Kenya 4
MX - Messico 4
NG - Nigeria 4
TW - Taiwan 4
BD - Bangladesh 3
CO - Colombia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
CU - Cuba 2
GR - Grecia 2
NP - Nepal 2
TH - Thailandia 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
VE - Venezuela 1
Totale 15.790
Città #
Warsaw 1.026
Woodbridge 969
Fairfield 933
Ann Arbor 875
Chandler 828
Houston 817
Jacksonville 554
Ashburn 542
Wilmington 459
Seattle 420
Trieste 372
Hong Kong 353
Cambridge 304
Singapore 293
Princeton 259
Boardman 235
Sofia 191
Beijing 164
Izmir 151
Columbus 149
Dublin 149
Toronto 103
Dearborn 79
Milan 67
San Diego 66
Falls Church 58
Dakar 54
Bern 52
Helsinki 45
Venezia 42
Brussels 40
Dong Ket 40
Redmond 40
Redwood City 38
Des Moines 36
Santa Clara 34
Chicago 29
Krefeld 29
Udine 28
Rome 25
Verona 25
Bremen 20
Grafing 20
Munich 20
Mestre 19
Norwalk 19
Seoul 19
Shanghai 19
Phoenix 18
Düsseldorf 17
Jinan 16
Kunming 16
Los Angeles 15
Washington 15
Fremont 14
Guangzhou 14
Ottawa 14
Brno 12
Buffalo 12
London 12
Nanchang 12
Nanjing 12
Dallas 11
Venice 11
Hefei 10
Oklahoma City 10
Amsterdam 9
Naples 9
New York 9
Shenyang 9
Turin 9
Fuzhou 8
Menlo Park 8
New Haven 8
Padova 8
Palermo 8
Shenzhen 8
São Paulo 8
Taiyuan 8
Duino-Aurisina 7
Gattaran 7
Jakarta 7
Lozzo di Cadore 7
Pune 7
San Vito Al Tagliamento 7
Alba 6
Central 6
Edinburgh 6
Kocaeli 6
Maniago 6
Piscataway 6
Stockholm 6
Tel Aviv 6
Wuhan 6
Basel 5
Bologna 5
Derby 5
Florence 5
Modena 5
Munro 5
Totale 11.585
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 380
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 352
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 338
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 308
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 302
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 279
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 275
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 270
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 253
Gut microbiota characterisation in obese patients before and after bariatric surgery 219
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 191
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 181
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 176
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 175
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 173
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 167
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 167
Anatomy of Basal Ganglia and Thalamus 166
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 164
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 163
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 163
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 154
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 153
null 145
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 144
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 144
null 143
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 142
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 140
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 140
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 139
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 138
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 136
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 136
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 135
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 134
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 133
null 132
null 129
null 128
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 128
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 125
null 125
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 125
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 125
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 123
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 122
Visual impairments and attention in parkinson's disease 121
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 121
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 119
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 119
null 119
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 116
Stem cells in the development of hepatocellular carcinoma: identification and expression 113
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 113
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 111
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 111
Deep brain stimulation of the subthalamus: Neuropsychological effects 111
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 111
null 110
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 110
null 109
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 109
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 108
null 107
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 106
null 105
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 105
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 103
null 101
null 101
null 100
null 96
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 96
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 95
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 94
Severity of liver disease with different hepatitis C viral clones. 93
null 90
null 89
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 89
null 87
Spontaneous porto-femoral shunting in long-standing portal hypertension 87
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 85
Hepatocellular carcinoma in the non-cirrhotic liver in Northern Italy: a retrospective study 85
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 85
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 82
Diverticular Disease and Rifaximin: An Evidence-Based Review 80
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 80
null 79
Variazioni della perfusione dell’epatocarcinoma dopo trattamento con talidomide 79
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 79
null 78
Epidemiologia del carcinoma epatocellulare 76
null 75
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 74
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 73
Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery 73
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 72
Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy 71
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 71
Totale 13.452
Categoria #
all - tutte 50.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.031 0 0 0 0 280 439 280 315 247 162 209 99
2020/20212.303 186 141 193 253 213 233 184 198 106 215 120 261
2021/20221.868 60 98 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.574 116 90 73 101 171 135 270 314 30 50 130 94
2024/2025971 64 71 185 363 288 0 0 0 0 0 0 0
Totale 16.456